Shabnam Kazmi

Shabnam Kazmi is an experienced CEO, CBO and Founder with over 30 years in the pharmaceutical and biotechnology industries, specializing in oncology.  She currently serves as CEO of Asellus Ventures, providing strategic advisory services to early stage oncology companies and investing in innovative healthcare technologies.  Shabnam holds a Harvard MBA and has deep experience with end to end product development and commercialization, business development, fundraising and go-to-market strategy for oncology compounds in both solid tumors and hematology.

Shabnam has a track record of delivering revenue upside and leading joint ventures and complex projects. She has owned P&Ls of over $1B and consistently delivered beyond corporate expectations. Shabnam is known for setting bold goals and vision and mobilizing teams and business partners to deliver against those goals.  She has led product launches in both solid tumors and hematology products and owned P&L responsibility for over a dozen oncology products, in tumors such as breast, colon, ovarian and lung cancers and in stem cell transplantation.

Shabnam has extensive experience in global business operations, having led a successful multi-company team across 75 countries to secure and grow an $8B business. Anticipating and managing business risk was a key element of this project and it provides Shabnam with a unique perspective on US, Europe and worldwide risk management.

Shabnam has a Bachelor’s Degree in Biochemistry and Economics from Smith College and an MBA from Harvard Business School.